Cargando…
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Cancer immunotherapy relies upon the ability of T cells to infiltrate tumors. The endothelium constitutes a barrier between the tumor and effector T cells, and the ability to manipulate local vascular permeability could be translated into effective immunotherapy. Here, we show that in the context of...
Autores principales: | Facciabene, Andrea, De Sanctis, Francesco, Pierini, Stefano, Reis, Edimara S., Balint, Klara, Facciponte, John, Rueter, Jens, Kagabu, Masahiro, Magotti, Paola, Lanitis, Evripidis, DeAngelis, Robert A., Buckanovich, Ronald J., Song, Wenchao C., Lambris, John D., Coukos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599081/ https://www.ncbi.nlm.nih.gov/pubmed/28932632 http://dx.doi.org/10.1080/2162402X.2017.1326442 |
Ejemplares similares
-
Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015) -
Complexity of complement activation in sepsis
por: Markiewski, Maciej M, et al.
Publicado: (2008) -
Editorial: Therapeutic Modulation of the Complement System: Clinical Indications and Emerging Drug Leads
por: Mastellos, Dimitrios C., et al.
Publicado: (2020) -
Modulation of the anti-tumor immune response by complement
por: Markiewski, Maciej M., et al.
Publicado: (2008) -
Control of endothelial quiescence by FOXO-regulated metabolites
por: Andrade, Jorge, et al.
Publicado: (2021)